Ji-young E. Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Therapeutic effect of IL-11 inhibition on the pathogenesis of thyroid eye disease.
Journal: Journal of molecular endocrinology
Published: June 02, 2025
Therapeutic role of physalin A in the pathogenesis of Graves' orbitopathy.
Journal: Immunopharmacology and immunotoxicology
Published: November 04, 2024
Potential Therapeutic Role of Bone Morphogenic Protein 7 (BMP7) in the Pathogenesis of Graves' Orbitopathy.
Journal: Investigative ophthalmology & visual science
Published: June 07, 2022
PERK mediates oxidative stress and adipogenesis in Graves' orbitopathy pathogenesis.
Journal: Journal of molecular endocrinology
Published: April 15, 2021
Signal transducer and activator of transcription 3 as a potential therapeutic target for Graves' orbitopathy.
Journal: Molecular and cellular endocrinology
Published: February 22, 2021
Role of binding immunoglobulin protein (BiP) in Graves' orbitopathy pathogenesis.
Journal: Journal of molecular endocrinology
Published: September 21, 2020
Anti-oxidative and anti-adipogenic effects of caffeine in an in vitro model of Graves' orbitopathy.
Journal: Endocrine journal
Published: January 17, 2020
Development of the Korean Global Physical Activity Questionnaire: reliability and validity study.
Journal: Global health promotion
Published: August 04, 2019
Dendropanax morbiferus leaf extract facilitates oligodendrocyte development.
Journal: Royal Society open science
Published: February 13, 2019
Inhibitory Effect of Idelalisib, a Selective Phosphatidylinositol 3-Kinase δ Inhibitor, on Adipogenesis in an In Vitro Model of Graves' Orbitopathy.
Journal: Investigative ophthalmology & visual science
Published: September 08, 2018
Last Updated: 09/26/2026